Breast cancer metastasis: markers and models
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and distant organs. At primary diagnosis, prognostic markers are used to assess whether the transition to systemic disease is likely to have occurred. The prevailing model of metastasis reflects this view--it suggests that metastatic capacity is a late, acquired event in tumorigenesis. Others have proposed the idea that breast cancer is intrinsically a systemic disease. New molecular technologies, such as DNA microarrays, support the idea that metastatic capacity might be an inherent feature of breast tumours. These data have important implications for prognosis prediction and our understanding of metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune cells were shown to both enhance and inhibit malignant cells proliferation, migration, and metastasis [125-128].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [125]
In the citing paper
“Chemical gradients play an important role in tumor cell invasion of metastatic cancer [195,196] as it significantly directs the migration and differentiation of tumor cells.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [196]
In the citing paper
“Metastasis is the leading cause of death from breast cancer1, 37-39.”
From Liposomal Formulation of HIF-1α Inhibitor Echinomycin Eliminates Established Metastases of Triple-negative Breast Cancer (2020) · cites this paper as [1]
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“ERBB2 is overexpressed due to gene amplification in 15–30% of human breast cancer”
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
Self-citationA Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
ELSTON, C. W., & ELLIS, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,175 · cited 1×
“Established prognostic markers The risk of metastasis development increases with the presence of lymph-node metastasis, a larger-sized primary tumour and loss of histopathological differentiation (grade”
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Pathology and Genetics of Tumours of the Breast and Female Genital Organs
Tavassoli, F. A., & Devilee, P. (2003) · International Agency for Research on Cancer eBooks · Cited by 2,800
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
A molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
Carter, C. L., Allen, C., & Henson, D. E. (1989) · Cancer · doi:10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h · Cited by 2,288
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Haagenson, C. (1971) · Cited by 1,773
Pathological prognostic factors in breast cancer
Elston, C. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00034-7 · Cited by 1,735
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<119::aid-ijc17>3.0.co;2-e · Cited by 1,552
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
Computational analysis of microarray data
Quackenbush, J. (2001) · Nature Reviews Genetics · doi:10.1038/35076576 · Cited by 1,471
Metastasis Results from Preexisting Variant Cells Within a Malignant Tumor
Fidler, I. J., & Kripke, M. L. (1977) · Science · doi:10.1126/science.887927 · Cited by 1,425
Selection of Successive Tumour Lines for Metastasis
FIDLER, I. J. (1973) · Nature New Biology · doi:10.1038/newbio242148a0 · Cited by 1,361
(1970) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/45.4.773 · Cited by 1,025
Chang, H. Y., Nuyten, D. S. A., Sneddon, J. B., Hastie, T., Tibshirani, R., Sørlie, T., Dai, H., He, Y. D., van't Veer, L. J., Bartelink, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409462102 · Cited by 981
Ma, X.-J., Wang, Z., Ryan, P. D., Isakoff, S. J., Barmettler, A., Fuller, A., Muir, B., Mohapatra, G., Salunga, R., Tuggle, J. T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.015 · Cited by 954 · cited 1×
“showed that the expression ratio of the two genes HIXB13 and IL17BL accurately predicts metastatis developmen”
Chang, H. Y., Sneddon, J. B., Alizadeh, A. A., Sood, R., West, R. B., Montgomery, K., Chi, J.-T., Rijn, M. V. D., Botstein, D., & Brown, P. O. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020007 · Cited by 951 · cited 1×
“Interestingly, using published DNA-microarray data, a gene-expression signature was developed that is associated with the serum response in fibroblasts, and it was able to predict metastasis risk in different kinds of human tumour, including breast, prostate, lung, gastric and hepatocellular carcinoma”
Braun, S., Pantel, K., Müller, P., Janni, W., Hepp, F., Kentenich, C. R. M., Gastroph, S., Wischnik, A., Dimpfl, T., Kindermann, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420801 · Cited by 923
Self-renewal and solid tumor stem cells
Al-Hajj, M., & Clarke, M. F. (2004) · Oncogene · doi:10.1038/sj.onc.1207947 · Cited by 914
(2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.979 · Cited by 893
Gene expression profiles of human breast cancer progression
Ma, X.-J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931261100 · Cited by 887
Chang, J. C., Wooten, E. C., Tsimelzon, A., Hilsenbeck, S. G., Gutierrez, M. C., Elledge, R., Mohsin, S., Osborne, C. K., Chamness, G. C., Allred, D. C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14023-8 · Cited by 875
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
Arpino, G., Bardou, V. J., Clark, G. M., & Elledge, R. M. (2004) · Breast Cancer Research · doi:10.1186/bcr767 · Cited by 865
Walker, R. A. (2005) · Histopathology · doi:10.1111/j.1365-2559.2004.02026.x · Cited by 839
Outcome signature genes in breast cancer: is there a unique set?
Ein-Dor, L., Kela, I., Getz, G., Givol, D., & Domany, E. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth469 · Cited by 802
Metastasis genes: A progression puzzle
Bernards, R., & Weinberg, R. A. (2002) · Nature · doi:10.1038/418823a · Cited by 798
Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers
Hayes, D. F., Bast, R. C., Desch, C. E., Fritsche, H., Kemeny, N. E., Jessup, J. M., Locker, G. Y., Macdonald, J. S., Mennel, R. G., Norton, L., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1456 · Cited by 748
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
Minn, A. J., Kang, Y., Serganova, I. S., Gupta, G. P., Giri, D. D., Doubrovin, M., Ponomarev, V., Gerald, W. L., Blasberg, R. G., & Massagué, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522320 · Cited by 742
Evaluation of gene expression measurements from commercial microarray platforms
Tan, P. K. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg763 · Cited by 706
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
Goldhirsch, A., Wood, W. C., Senn, H.-J., Glick, J. H., & Gelber, R. D. (1995) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/87.19.1441 · Cited by 689
Schmidt-Kittler, O., Ragg, T., Daskalakis, A., Granzow, M., Ahr, A., Blankenstein, T. J. F., Kaufmann, M., Diebold, J., Arnholdt, H., Müller, P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1331931100 · Cited by 631
Gene expression predictors of breast cancer outcomes
Huang, E., Cheng, S. H., Dressman, H., Pittman, J., Tsou, M. H., Horng, C. F., Bild, A., Iversen, E. S., Liao, M., Chen, C. M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13308-9 · Cited by 627
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
Ross, J. S., Fletcher, J. A., Linette, G. P., Stec, J., Clark, E., Ayers, M., Symmans, W. F., Pusztai, L., & Bloom, K. J. (2003) · The Oncologist · doi:10.1634/theoncologist.8-4-307 · Cited by 610
Look, M. P., van Putten, W. L. J., Duffy, M. J., Harbeck, N., Christensen, I. J., Thomssen, C., Kates, R., Spyratos, F., Ferno, M., Eppenberger-Castori, S., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.2.116 · Cited by 596
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., & Senn, H.-J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3817 · Cited by 582
Ayers, M., Symmans, W. F., Stec, J., Damokosh, A. I., Clark, E., Hess, K., Lecocke, M., Metivier, J., Booser, D., Ibrahim, N., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.166 · Cited by 566
Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast.
Borst, M. J., & Ingold, J. A. (1993) · PubMed · Cited by 514
Bias as a threat to the validity of cancer molecular-marker research
Ransohoff, D. F. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1550 · Cited by 487
Diel, I. J., Kaufmann, M., Costa, S. D., Holle, R., von Minckwitz, G., Solomayer, E. F., Kaul, S., & Bastert, G. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.22.1652 · Cited by 477
Janicke, F., Prechtl, A., Thomssen, C., Harbeck, N., Meisner, C., Untch, M., Sweep, C. G. J. F., Selbmann, H.-K., Graeff, H., & Schmitt, M. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.12.913 · Cited by 434
Gene expression profiles of primary breast tumors maintained in distant metastases
Weigelt, B., Glas, A. M., Wessels, L. F. A., Witteveen, A. T., Peterse, J. L., & van't Veer, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2634067100 · Cited by 431 · cited 1×
“Furthermore, it was reported that pairs of human primary breast carcinomas and their distant metastases, which developed years later, are highly similar at their transcriptome leve”
Self-citationThe urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.
Foekens, J. A., Peters, H. A., Look, M. P., Portengen, H., Schmitt, M., Kramer, M. D., Brünner, N., Jänicke, F., Gelder, M. E. M., Henzen-Logmans, S. C., et al. (2000) · PubMed · Cited by 419
Karnofsky Memorial Lecture. Natural history of small breast cancers.
Hellman, S. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.10.2229 · Cited by 418
Breast carcinoma: Pattern of metastasis at autopsy
Lee, Y. N. (. (1983) · Journal of Surgical Oncology · doi:10.1002/jso.2930230311 · Cited by 406 · cited 1×
“The common sites for metastatic spread are bone, lung and liver (reviewed in Ref”
Gudjonsson, T., Villadsen, R., Nielsen, H. L., Rønnov-Jessen, L., Bissell, M. J., & Petersen, O. W. (2002) · Genes & Development · doi:10.1101/gad.952602 · Cited by 390
Koscielny, S., Tubiana, M., Lê, M. G., Valleron, A. J., Mouriesse, H., Contesso, G., & Sarrazin, D. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.112 · Cited by 358
Rosen, P. P., Groshen, S., Saigo, P. E., Kinne, D. W., & Hellman, S. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.9.1239 · Cited by 355
Stathopoulou, A., Vlachonikolis, I., Mavroudis, D., Perraki, M., Kouroussis, C., Apostolaki, S., Malamos, N., Kakolyris, S., Kotsakis, A., Xenidis, N., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.135 · Cited by 335
Harris, J. R. (2014) · Cited by 325
A putative human breast stem cell population is enriched for steroid receptor-positive cells
Clarke, R. B., Spence, K., Anderson, E., Howell, A., Okano, H., & Potten, C. S. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2004.07.044 · Cited by 321
Targeted Therapy in Breast Cancer
Ross, J. S., Fletcher, J. A., Bloom, K. J., Linette, G. P., Stec, J., Symmans, W. F., Pusztai, L., & Hortobagyi, G. N. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r400001-mcp200 · Cited by 303
Yamauchi, H., Stearns, V., & Hayes, D. F. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2334 · Cited by 291
Breast cancer, stem/progenitor cells and the estrogen receptor
Dontu, G., El-Ashry, D., & Wicha, M. S. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.05.011 · Cited by 288
PINDER, S. E., ELLIS, I. O., GALEA, M., O'ROUKE, S., BLAMEY, R. W., & ELSTON, C. W. (1994) · Histopathology · doi:10.1111/j.1365-2559.1994.tb01269.x · Cited by 287
Wiedswang, G., Borgen, E., Kåresen, R., Kvalheim, G., Nesland, J. M., Qvist, H., Schlichting, E., Sauer, T., Janbu, J., Harbitz, T., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.009 · Cited by 284
Prognostic Factors and Treatment Decisions in Axillary-Node-Negative Breast Cancer
Desforges, J. F., McGuire, W. L., & Clark, G. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262607 · Cited by 282
Prognostic Factors and Therapeutic Decisions in Axillary Node-Negative Breast Cancer
Elledge, R. M., & McGuire, W. L. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001221 · Cited by 257
Context, tissue plasticity, and cancerAre tumor stem cells also regulated by the microenvironment?
BISSELL, M., & LABARGE, M. (2005) · Cancer Cell · doi:10.1016/s1535-6108(04)00375-7 · Cited by 255
Jänicke, F., Schmitt, M., & Graeff, H. (1991) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002624 · Cited by 227
Pierga, J.-Y., Bonneton, C., Vincent-Salomon, A., de Cremoux, P., Nos, C., Blin, N., Pouillart, P., Thiery, J.-P., & Magdelénat, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0102-03 · Cited by 223
Funke, I., & Schraut, W. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.557 · Cited by 217
Circulating tumour cells in breast cancer
Ring, A., Smith, I. E., & Dowsett, M. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01381-6 · Cited by 196
Harbeck, N., Kates, R. E., Look, M. P., Gelder, M. E. M., Klijn, J. G. M., Krüger, A., Kiechle, M. B., Jänicke, F., Schmitt, M., & Foekens, J. A. (2002) · PubMed · Cited by 191
Prognosis and Breast Cancer: Recognition of Lethal and Favorable Prognostic Types
Page, D. L. (1991) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199104000-00002 · Cited by 189
Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1
Hayashi, Y., Kanda, N., Inaba, T., Hanada, R., Nagahara, N., Muchi, H., & Yamamoto, K. (1989) · Cancer · doi:10.1002/1097-0142(19890101)63:1<126::aid-cncr2820630120>3.0.co;2-z · Cited by 182
Esteva, F. J., Sahin, A. A., Cristofanilli, M., Coombes, K., Lee, S.-J., Baker, J., Cronin, M., Walker, M., Watson, D., Shak, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1707 · Cited by 168
Bajou, K., Maillard, C., Jost, M., Lijnen, R. H., Gils, A., Declerck, P., Carmeliet, P., Foidart, J.-M., & Noel, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207859 · Cited by 164
Dynamic Heterogeneity: Rapid Generation of Metastatic Variants in Mouse B16 Melanoma Cells
Hill, R. P., Chambers, A. F., Ling, V. W. T., & Harris, J. F. (1984) · Science · doi:10.1126/science.6719130 · Cited by 153
James, J. J., Evans, A. J., Pinder, S. E., Gutteridge, E., Cheung, K., Chan, S. Y. T., & Robertson, J. F. R. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601198 · Cited by 138
Distinct lung-colonizing and lung-metastasizing cell populations in B16 mouse melanoma
Stackpole, C. W. (1981) · Nature · doi:10.1038/289798a0 · Cited by 128
Harbeck, N., Kates, R. E., & Schmitt, M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.4.1000 · Cited by 121
Kerbel, R. S., Waghorne, C. G., Man, M. S., Elliott, B. E., & Breitman, M. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1263 · Cited by 119 · cited 1×
“The 'clonal dominance' theory of metastasis, however, proposes that once a metastatic subclone emerges within a primary tumour, the progeny of this subclone overgrow and dominate the tumour mass itsel”
Garcı́a-Olmo, D. C., Dc, G.-O., Ontañón, J., Martinez, E., & Vallejo, M. (1999) · PubMed · doi:10.14670/hh-14.1159 · Cited by 114
Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours
Giavazzi, R., Alessandri, G., Spreafico, F., Garattini, S. K., & Mantovani, A. (1980) · British Journal of Cancer · doi:10.1038/bjc.1980.259 · Cited by 106
Rs, K., Waghorne, C. G., Korczak, B. M., Lagarde, A., & Ml, B. (1988) · PubMed · Cited by 104
Gangnus, R., Langer, S., Breit, E., Pantel, K., & Speicher, M. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0818 · Cited by 102
de Mascarel, I., Bonichon, F., Durand, M., Mauriac, L., MacGrogan, G. M., Soubeyran, I., Picot, V., Avril, A., Coindre, J., & Trojani, M. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00344-4 · Cited by 97 · cited 1×
“In patients with tumour-negative axillary lymph nodes, vessel invasion is an additional predictor for distant recurrenc”
Veer, L. J. V., & Weigelt, B. (2003) · Nature Medicine · doi:10.1038/nm0803-999b · Cited by 97
Self-citationQuantitative genetic analysis of tumor progression
Ling, V. W. T., Chambers, A. F., Harris, J. F., & Hill, R. P. (1985) · Cancer and Metastasis Reviews · doi:10.1007/bf00050694 · Cited by 88 · cited 1×
“The 'dynamic heterogeneity' model proposes that metastatic subpopulations are generated at high rates in a primary tumour, but that these variants are relatively unstable, resulting in a dynamic equilibrium between generation and loss of metastatic variant”
Landys, K. E., Persson, S., Kovařík, J., Hultborn, R., & Holmberg, E. C. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005980919916 · Cited by 82
Functionality of Circulating DNA
García‐Olmo, D., & GARCÍA‐OLMO, D. C. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03895.x · Cited by 74
Do metastases arise from pre-existing subpopulations of cancer cells?
Weiss, L., Holmes, J. C., & Ward, P. M. (1983) · British Journal of Cancer · doi:10.1038/bjc.1983.10 · Cited by 70
Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours
Eccles, S. A., Heckford, S. E., & Alexander, P. M. (1980) · British Journal of Cancer · doi:10.1038/bjc.1980.224 · Cited by 66
Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.
Konecny, G. E., Untch, M., Arboleda, J., Wilson, C., Kahlert, S., Boettcher, B., Felber, M., Beryt, M., Lude, S., Hepp, H., et al. (2001) · PubMed · Cited by 65
Molino, A., Pelosi, G., Turazza, M., Sperotto, L., Bonetti, A. V., Nortilli, R., Fattovich, G., Alaimo, C., Piubello, Q., Pavanel, F., et al. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005747711084 · Cited by 64
Characterization of tumor lines derived from spontaneous metastases of a transplanted murine sarcoma
Mantovani, A., Giavazzi, R., Alessandri, G., Spreafico, F., & Garattini, S. K. (1981) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(81)90213-9 · Cited by 58
Umeda, T., Eguchi, Y., Okino, K., Kodama, M., & Hattori, T. (1997) · The Journal of Pathology · Cited by 57
Spontaneous metastasis: random or selective?
Milas, L., Peters, L. J., & Ito, H. (1983) · Clinical & Experimental Metastasis · doi:10.1007/bf00121193 · Cited by 39
Modifiers of mammary tumor progression and metastasis on mouse Chromosomes 7, 9, and 17
Lancaster, M., Rouse, J., & Hunter, K. W. (2005) · Mammalian Genome · doi:10.1007/s00335-004-2432-y · Cited by 38
Prognostic value of tumour cell detection in peripheral blood of breast cancer patients.
Zach, O., Kasparu, H., Wagner, H., Krieger, O., & Lutz, D. (2002) · PubMed · Cited by 35
Gebauer, G., Fehm, T. N., Merkle, E., Jaeger, W., & Mitze, M. (2003) · PubMed · Cited by 34
Ismail, M. S., Wynendaele, W., Aerts, J. L., Paridaens, R., Gaafar, R. M., Shakankiry, N. E., Khaled, H. M., Christiaens, M.-R., Wildiers, H. P. M. W., Omar, S. R., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0515-2 · Cited by 32
Metastasizing potentials of mouse mammary tumors and their metastases
Vaage, J. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410614 · Cited by 31
Tumours : wounds that do not heal.
Ridgway, P. F. (2002) · Europe PMC (PubMed Central) · Cited by 22
A Big Trial for a New Technology: TransBIG Project Takes Microarrays Into Clinical Trials
Tuma, R. S. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/96.9.648 · Cited by 17
Kareem, B. N., Karlsen, F., Holm, R., Hennig, E. M., Suo, Z., Emilsen, E., Hellesylt, E., & Nesland, J. M. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199712)183:4<424::aid-path949>3.0.co;2-l · Cited by 4
Research works printed but not linked: 2
- Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumour embolilabeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773–782 (1970).
- Leighton, J. Inherent malignancy of cancer cells possibly limited by genetically differing cells in the same tumour. Acta Cytol. 9, 138–140 (1965).
Cited by
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
“Recent advances in the molecular profiling of cancer using genomic-level approaches have revealed genes whose expression in primary tumors correlates strongly with the likelihood of metastatic recurrence (Weigelt et al., 2005).”
BackgroundPhenotypic characterization of human colorectal cancer stem cells
Dalerba, P., Dylla, S. J., Park, I.-K., Liu, R., Wang, X., Cho, R. W., Hoey, T., Gurney, A., Huang, E. H., Simeone, D. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703478104 · Cited by 2,184
Metastasis: a question of life or death
Mehlen, P., & Puisieux, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1886 · Cited by 1,863
“Metastases are the cause of 90% of human cancer death”
BackgroundEndogenous human microRNAs that suppress breast cancer metastasis
Tavazoie, S. F., Alarcón, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L., & Massagué, J. (2008) · Nature · doi:10.1038/nature06487 · Cited by 1,857
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,486
Metadata
- Authors
- Weigelt, B., Peterse, J. L., & van't Veer, L. J.
- Affiliations
- The Netherlands Cancer Institute (NL)
- ORCID
- Weigelt, Britta
- Venue
- Nature Reviews Cancer
- Published
- 2005-08-01
- Volume
- 5
- Issue
- 8
- Pages
- 591-602
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2004280628
- Semantic Scholar
- 3bd1490d7b6c8daa59bd35260c6c71e39d3d62fa
- Cited by
- 2,232
- References
- 112
- Citations by year
- 2026: 34 · 2025: 69 · 2024: 90 · 2023: 111 · 2022: 139 · 2021: 154 · 2020: 159 · 2019: 147 · 2018: 140 · 2017: 191 · 2016: 162 · 2015: 152 · 2014: 121 · 2013: 104 · 2012: 88
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- breast cancer, metastasis, prognostic factors, metastatic potential, lymph node metastasis, distant metastasis, carcinogenesis, DNA microarrays, systemic disease, metastasis model
- MeSH terms
- Breast Neoplasms, Female, Humans, Neoplasm Metastasis, Biomarkers, Tumor, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.